Coherus Oncology, Inc.CHRSNASDAQ

Revenue (LTM)

$42M

-84.2% YoY

Net Income (LTM)

$-170M

-697.4% YoY

Free Cash Flow

$-139M

Revenue CAGR (5Y)

-38.4%

Marginsdeclining

FCF($0.1B)

Now unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	327	211↓35.4%	257↑21.9%	267↑3.8%	42↓84.2%
Gross Profit	269	141↓47.6%	98↓30.3%	149↑52.1%	24↓83.6%
Operating Income	-264	-257↑2.6%	-203↑20.9%	-112↑45.0%	-180↓60.8%
Net Income	-287	-292↓1.6%	-238↑18.5%	29↑112.0%	-170↓697.4%
EBITDA	-261	-256↑2.0%	-194↑24.1%	61↑131.4%	-176↓388.2%
EPS Diluted	-3.81	-3.76↑1.3%	-2.53↑32.7%	0.25↑109.9%	-1.45↓680.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	417	64↓84.8%	103↑61.9%	126↑22.4%	89↓29.5%
Total Current Assets	602	381↓36.7%	476↑24.8%	342↓28.2%	193↓43.5%
Total Assets	679	481↓29.2%	630↑30.9%	449↓28.8%	258↓42.4%
Total Current Liabilities	165	139↓16.1%	332↑139.2%	283↓14.7%	142↓49.9%
Total Liabilities	582	618↑6.3%	823↑33.1%	581↓29.5%	197↓66.0%
Total Equity	98	-137↓240.6%	-193↓40.8%	-132↑31.8%	61↑146.2%
Total Debt	419	480↑14.7%	481↑0.1%	270↓43.9%	54↓79.9%
Net Debt	2	417↑22705.0%	378↓9.3%	144↓61.9%	-35↓124.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-37	-241↓544.2%	-175↑27.5%	-20↑88.3%	-139↓577.7%
Capital Expenditure	-1	-2↓58.2%	-0↑86.0%	0	0
Free Cash Flow	-39	-243↓528.0%	-175↑28.0%	-20↑88.3%	-139↓577.7%
Stock-Based Comp	51	51↓1.2%	43↓15.0%	28↓35.5%	0
Net Change in Cash	-124	-354↓185.3%	39↑111.1%	23↓41.8%	-37↓262.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance